No Data
AIA (01299) spent HKD 62.1486 million on January 3 to repurchase 1.1198 million shares.
AIA (01299) announced that it will spend HKD 62.1486 million to repurchase shares on January 3, 2025...
Express News | Hong Kong Stock Exchange: AIA Group repurchased 1.1 million shares of Stocks at HKD 62.1 million on January 3.
Goldman Sachs has updated the leading Indicators (ERLI) and compiled a list of Buy recommendations for Hong Kong stocks (table).
Goldman Sachs published the January Asia-Pacific strategy report, listing the latest Buy stocks (only Hong Kong stocks) based on the Earnings Revision Leading Indicator (ERLI): China Construction Bank (00939.HK), AIA (01299.HK), Hong Kong Stock Exchange (00388.HK), Ping An Insurance (02318.HK), Techtronic Industries (00669.HK), CKH HOLDINGS (00001.HK), China Life (02628.HK), BOC HONG KONG (02388.HK), ZTO Express.
Express News | Hong Kong stock companies have repurchased a total of 265.7 billion HKD in 2024, with Tencent leading the pack.
January 2 repurchase summary | TENCENT, ANTA SPORTS and others have repurchased shares, among which TENCENT spent 0.701 billion Hong Kong dollars.
According to a document disclosed by HKEX on January 3, TENCENT (00700.HK), ANTA SPORTS (02020.HK), and others repurchased shares. ① TENCENT (00700.HK) repurchased 1.68 million ordinary shares on January 2, involving an amount of 0.701 billion Hong Kong dollars, with a repurchase price ranging from 424.6 to 413.8 Hong Kong dollars per share. Since the repurchase authorization resolution, the cumulative number of securities repurchased has been 0.232 billion shares, accounting for 2.463% of the number of issued shares at the time the ordinary resolution was passed. ② ANTA SPORTS (02020.HK) on January 2.
Selected Announcements | Alibaba's buyback plan still has a remaining amount of 20.7 billion USD; GTJA plans to conduct a stock swap to absorb and merge HAITONG SEC and will send a proposal to the meeting for fundraising support.
In 2024, Qinhuangdao Port's total throughput reached 0.414 billion tons, a year-on-year increase of 5.66%; ZHAOKE OPHTH-B: The National Medical Products Administration accepted the simplified new drug application for NVK002, used to treat worsening myopia in children.